Form 4: Amgen SVP of Human Resources, Derek Miller, Reports Acquisition of Common Stock

Derek Miller, SVP of Human Resources at Amgen, reports acquiring 2,005 shares of common stock on March 3, 2025.

Summary

• On March 3, 2025, Derek Miller, SVP of Human Resources at Amgen, acquired 2,005 shares of Amgen common stock.
• The acquisition price was $0 per share.
• Following the transaction, Miller directly owns 10,549 shares of Amgen common stock.
• These shares include 153 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.
• DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing a stock transaction. The acquisition of shares by an executive is generally viewed as a positive signal, but the document itself is purely informational.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often seen as a sign of confidence in the company.

Key Dates